Physician

Tyron A Alli, M.D.

According to 2025 Medicare claims, Tyron Alli, M.D. (NPI: 1447225784) practices gastroenterology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is MIDWEST GASTROINTESTINAL ASSOCIATES PC (NPI: 1073569125; TIN: 470772952) and primary practice location at 68114-4032. Alli is affiliated with the Nebraska Health Network, LLC (ACO ID: A3273), NPG Health Collaborative LLC (ACO ID: A3287), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Alli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 762 traditional Medicare patients, billed 35,901 HCPCS/CPT codes, and received $694,380 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,428 prescription claims across 550 beneficiaries totaling $692,801 in drug costs, led by Sucraid (Sacrosidase). 2019 DME data shows 165 claims. Open Payments data shows 57 records totaling $2,637. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $261,541 to $694,380. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $752,124 and ending at $692,801. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	841	3,575	$261,541
2016	892	6,457	$278,920
2017	948	9,064	$304,335
2018	982	11,092	$418,138
2019	922	17,924	$596,560
2020	744	19,925	$558,847
2021	808	20,291	$563,371
2022	809	31,880	$707,052
2023	786	29,997	$641,581
2024	762	35,901	$694,380

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	381	1,177	$752,124
2016	388	1,093	$476,730
2017	461	1,209	$682,302
2018	456	1,291	$310,796
2019	474	1,316	$502,041
2020	468	1,234	$310,140
2021	522	1,272	$594,419
2022	471	1,242	$999,002
2023	490	1,237	$577,951
2024	550	1,428	$692,801

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	83	$48,826
2019	N/R	165	$99,873
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	165	165	$187
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	113	$82
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	166	170	$71
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	96	172	$57
36415	Insertion of needle into vein for collection of blood sample	67	88	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sucraid	Sacrosidase	11	320	$147,319
Ocaliva	Obeticholic Acid	12	360	$122,688
Xifaxan	Rifaximin	21	630	$78,965
Linzess	Linaclotide	35	1,114	$20,382
Mesalamine	Mesalamine	14	1,190	$7,959

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	57	$2,637	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tyron A. Alli, M.D.?

Tedicare shows public-source Medicare data for Tyron A. Alli, M.D. (NPI 1447225784), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tyron A. Alli, M.D. have ACO affiliation data?

Tyron A. Alli, M.D. is shown with ACO affiliation data for Nebraska Health Network, LLC (MSSP, ACO ID A3273), NPG Health Collaborative LLC (MSSP, ACO ID A3287), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Tyron A. Alli, M.D.?

Tyron A. Alli, M.D. is linked to MIDWEST GASTROINTESTINAL ASSOCIATES PC (billing NPI 1073569125) in the available physician profile data.

Does Tyron A. Alli, M.D. have Open Payments data?

Tyron A. Alli, M.D. has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.